Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa

Hidradenitis suppurativa Research


Author(s): Thomi R, Yerly D, Yawalkar N, Simon D, Schlapbach C, Hunger RE

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. Its immunopathogenic mechanisms are still poorly understood. Previous studies could demonstrate that the pro-inflammatory cytokine Interleukin-32 (IL-32) is implicated in the pathogenesis of other inflammatory diseases.

OBJECTIVES: The aim of our study was to investigate the tissue expression and systemic levels of IL-32 as well as its cellular sources in HS patients in comparison to healthy donors and to patients suffering from two other inflammatory skin diseases: psoriasis (PS) and atopic dermatitis (AD).

METHODS: Tissue samples were obtained from healthy skin and lesional HS, PS and AD skin to analyse the expression of IL-32 by immunohistochemistry and semi-quantitative real-time PCR. The cellular source of the cytokine was determined by double immunofluorescence staining. Serum of the four donors groups was used to measure systemic levels of IL-32 by enzyme-linked immunosorbent assay (ELISA).

RESULTS: IL-32 was upregulated in HS patients in both lesional skin and serum when compared to healthy donors or AD and PS patients. In HS, IL-32 was found to be expressed by NK cells, T cells, macrophages and dendritic cells in highly infiltrated areas of the dermis. High IL-32 mRNA levels in lesional HS skin coincided with high amounts of T cells and macrophages present. Additionally, IL-32 mRNA levels in lesional HS skin correlate positively with IFNγ and IL-17 and negatively with IL-13.

CONCLUSIONS: Our findings suggest that IL-32 is overexpressed in HS. Targeting IL-32 may therefore represent a new therapeutic option for the treatment of this recalcitrant disease. This article is protected by copyright. All rights reserved.


Dermatology Journal and/or Publisher

Journal Name: The British journal of dermatology
Journal Abbreviation: Br. J. Dermatol.
Journal Date Published: 2017-03-16


National Center for Biotechnology Information

PMID: 28301691
Article Source: http://www.ncbi.nlm.nih.gov/pubmed/28301691
Lasted Revision: 2017-03-16


Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for Hidradenitis suppurativa (HS).


0 Comments

Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Translate »

Log in with your credentials

Forgot your details?